Clearside Biomedical Poster Presentation at ARVO 2022 Annual Meeting Demonstrates Versatility of Suprachoroidal Delivery Technology
May 05, 2022 07:05 ET
|
Clearside Biomedical, Inc.
- Multiple Poster Presentations on XIPERE® and Gene Therapy Delivery Utilizing SCS Microinjector® - - Dr. Thomas Ciulla to Participate in a Panel Discussion at Retina World Congress 2022 on May 12,...
Insights on the Disposable Contact Lenses Global Market to 2027 - Featuring Johnson & Johnson, Alcon and Aqualens Among Others
May 02, 2022 05:03 ET
|
Research and Markets
Dublin, May 02, 2022 (GLOBE NEWSWIRE) -- The "Disposable Contact Lenses Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. This study...
Clearside Biomedical to Report First Quarter 2022 Financial Results and Provide Corporate Update on Wednesday, May 11, 2022
April 29, 2022 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., April 29, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Evo Visian® ICL Launches in the U.S.; an Evolutionary Vision Correction Procedure to Treat Nearsightedness is Now Available at Coastal Vision Medical Group
April 27, 2022 13:00 ET
|
Coastal Vision Medical Group (coastalvisionmedical.com)
CHINO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- EVO Visian® ICL ("EVO") is an evolutionary, clinically-proven implantable lens that corrects common vision problems such as nearsightedness and...
AXIM Develops Quantitative Rapid Diagnostic Test for Lacritin; Now Boasts Four Dry Eye Disease Point-of-Care Biomarker Tests
April 27, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting Dry Eye...
ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision and Ophthalmology (ARVO) 2022
April 26, 2022 16:10 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of...
Retrospective study covering 2,000 patients over 10 years using ForeseeHome AMD remote monitoring shows substantially better outcomes for patients
April 26, 2022 08:49 ET
|
Notal Vision
Manassas, VA, April 26, 2022 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today the publication of the Analysis of Long-term visual Outcomes of ForeseeHome Remote Telemonitoring (ALOFT) study...
Tarsus Presents Results of Two Studies Highlighting Demodex Blepharitis Patient Impact and Burden at the ASCRS 2022 Annual Meeting
April 26, 2022 08:30 ET
|
Tarsus Pharmaceuticals, Inc
IRVINE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize...
Coastal Vision Medical Group Opens New Location in Chino, CA
April 21, 2022 11:00 ET
|
Coastal Vision Medical Group
CHINO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Coastal Vision Medical Group, a premier multi-location ophthalmology practice specializing in cataract and LASIK surgery, has opened a new...
Provectus Biopharmaceuticals Seeks Stockholder Approval at 2022 Annual Meeting for Authority to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
April 19, 2022 16:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 19, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that, in conjunction with the filing of the Company’s preliminary 2022 proxy statement (Pre-14A), Provectus’...